CXCR7 antagonists

Compounds having formula (I) (structurally represented) or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in f...

Full description

Saved in:
Bibliographic Details
Main Authors Fan, Junfa, Lui, Rebecca M, Zhang, Penglie, McMahon, Jeffrey P, Zeng, Yibin, Powers, Jay P, Krasinski, Antoni, Lange, Christopher W
Format Patent
LanguageEnglish
Published 22.03.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Compounds having formula (I) (structurally represented) or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing the compounds in admixture with a pharmaceutically acceptable excipient.
Bibliography:Application Number: AU20130352304